日本人急性心不全患者におけるトルバプタンの有効性と安全性

基本情報

NCT ID: NCT01635517
ステータス: 完了
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 274
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

The aims of the present study are to investigate prospectively the clinical course and outcome of the hospitalized heart failure patients treated with tolvaptan for management of fluid retention and serum sodium levels of less than 140 mEq/L and also to analyze the factors related with the efficacy including outcome of tolvaptan therapy.

対象疾患

Heart Failure

依頼者（Sponsor）

Nippon Medical School, Musashi Kosugi Hospital(UNKNOWN)

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

実施施設 (1)

日本医科大学武蔵小杉病院

Kawasaki, Kanagawa, Japan